Skip to main content
OXFORD BIODYNAMICS PLC logo

OXFORD BIODYNAMICS PLC — Investor Relations & Filings

Ticker · OBD ISIN · GB00BD5H8572 LEI · 2138005Y1TK258O5U928 IL Professional, scientific and technical activities
Open in API
Filings indexed 416 across all filing types
Latest filing 2016-12-06 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL OBD

About OXFORD BIODYNAMICS PLC

https://www.oxfordbiodynamics.com/

Oxford BioDynamics PLC is a global biotechnology company advancing personalized healthcare by developing and commercializing precision medicine tests. The company's proprietary EpiSwitch® platform utilizes 3D genomics and epigenetic biomarkers to create diagnostic solutions for life-changing diseases, with a focus on oncology. Its portfolio of clinical tests includes the EpiSwitch® PSE, a blood test that assesses the likelihood of prostate cancer with high accuracy to help reduce unnecessary biopsies, and the EpiSwitch® CiRT, a test designed to predict a patient's therapeutic response to Immune Checkpoint Inhibitor cancer therapies. The platform enables the translation of 3D genome regulation into clinical applications for precision medicine at scale.

Recent filings

Filing Released Lang Actions
Admission to AIM and First Day of Dealings
Share Issue/Capital Change Classification · 99% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement from the London Stock Exchange's news service (RNS). The content announces the 'ADMISSION TO AIM' and 'FIRST DAY OF DEALINGS' for Oxford BioDynamics Plc, detailing the results of a placing (£20.0 million raised) and the resulting number of shares and market capitalization. This is a significant corporate action announcement related to listing and capital structure, but it is disseminated via the RNS system. Since it is a general regulatory announcement that doesn't fit perfectly into specific categories like CAP (Capital/Financing Update, which usually details the terms of the financing itself rather than the listing outcome) or SHA (Share Issue/Capital Change, which is broader), the most appropriate classification for a standard, time-sensitive regulatory news service release is RNS, especially given the explicit 'RNS Number' header and 'This information is provided by RNS' footer. It is not a full report (10-K, IR) nor a proxy/dividend notice.
2016-12-06 English
[accounts-balance-sheet]
Regulatory Filings
2016-10-13 English
Small company accounts made up to 2015-09-30
Regulatory Filings
2016-06-16 English
Total exemption small accounts made up to 2014-09-30
Regulatory Filings
2014-12-09 English
Total exemption small accounts made up to 2013-09-30
Regulatory Filings
2013-11-07 English
Small company accounts made up to 2012-09-30
Regulatory Filings
2012-11-15 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.